SINGAPORE, August 18 — AIGP Health, a clinician-founded AI health tech company based in Singapore, has officially received Class A regulatory approval from the Health Sciences Authority (HSA) for its proprietary AI-powered clinical assistant, making it the first company in Singapore to secure this designation for such a tool.
This milestone enables AIGP to commence distribution of its solution to clinics and telehealth providers nationwide, and beyond.
The platform, built by a team of practising doctors, leverages natural language processing to support health care professionals with real-time note-taking, patient data summarisation, and consultation prompts. Crucially, the system is not autonomous, all medical decisions remain under physician control, which aligns with HSA’s guidelines for low-risk medical software (Class A).
The approval affirms AIGP Health’s commitment to building tools that augment, rather than replace, human clinical judgement, a stance increasingly advocated by Singapore’s regulators as part of a broader framework for responsible AI in medicine.
“Regulatory approval isn’t just a milestone for us, it’s an affirmation of our belief that technology can support, not substitute, the human touch in health care,” said Dr Anindita Santosa, co-founder and CEO of AIGP Health.
“This approval allows us to move from pilots to deployment, and bring our platform to more clinics, GPs, and telehealth providers, easing the administrative burden for doctors and improving continuity of care for patients.”
AIGP’s solution has already been deployed in pilots across Singapore and Australia, where general practitioners use the AI assistant to streamline documentation, prompt relevant clinical questions during consults, and surface red flags in patient history.
The company is also working with Borderless Healthcare Group to expand into Indonesia and Malaysia, marking its regional growth trajectory.
With the Class A certification now secured, AIGP Health has begun commercial conversations with more health care providers, particularly telehealth platforms, which stand to benefit from the platform’s ability to pre-fill documentation, flag missing information, and improve consult quality in fast-paced digital settings.
In addition to regulatory approval, AIGP Health is now SOC 2 compliant, reflecting its adherence to industry best practices in data pri...







English (US)